BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25649007)

  • 1. Is INI1-retained small cell undifferentiated histology in hepatoblastoma unfavorable?
    Zhou S; Gomulia E; Mascarenhas L; Wang L
    Hum Pathol; 2015 Apr; 46(4):620-4. PubMed ID: 25649007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small Cell Undifferentiated Histology Does Not Adversely Affect Outcome in Hepatoblastoma: A Report From the Children's Oncology Group (COG) AHEP0731 Study Committee.
    Trobaugh-Lotrario A; Katzenstein HM; Ranganathan S; Lopez-Terrada D; Krailo MD; Piao J; Chung N; Randazzo J; Malogolowkin MH; Furman WL; McCarville EB; Towbin AJ; Tiao GM; Dunn SP; Langham MR; McGahren ED; Feusner J; Rodriguez-Galindo C; Meyers RL; O'Neill AF; Finegold MJ
    J Clin Oncol; 2022 Feb; 40(5):459-467. PubMed ID: 34874751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small cell undifferentiated variant of hepatoblastoma: adverse clinical and molecular features similar to rhabdoid tumors.
    Trobaugh-Lotrario AD; Tomlinson GE; Finegold MJ; Gore L; Feusner JH
    Pediatr Blood Cancer; 2009 Mar; 52(3):328-34. PubMed ID: 18985717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B; Bode U; von Schweinitz D
    Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidisciplinary management of hepatoblastoma in children: Experience from a developing country.
    Shanmugam N; Scott JX; Kumar V; Vij M; Ramachandran P; Narasimhan G; Reddy MS; Kota V; Munirathnam D; Kelgeri C; Sundaram K; Rela M
    Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27781375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular invasion is a prognostic indicator in hepatoblastoma.
    Shi Y; Commander SJ; Masand PM; Heczey A; Goss JA; Vasudevan SA
    J Pediatr Surg; 2017 Jun; 52(6):956-961. PubMed ID: 28347528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatoblastoma in a child of extremely low birth weight.
    Jaing TH; Hung IJ; Lin JN; Lien RI; Hsueh C; Lu CS
    Am J Perinatol; 2002 Apr; 19(3):149-53. PubMed ID: 12012290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant rhabdoid tumor mimicking hepatoblastoma: a case report and literature review.
    Wagner LM; Garrett JK; Ballard ET; Hill DA; Perry A; Biegel JA; Collins MH
    Pediatr Dev Pathol; 2007; 10(5):409-15. PubMed ID: 17929989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small cell undifferentiated (SCUD) hepatoblastomas: All malignant rhabdoid tumors?
    Vokuhl C; Oyen F; Häberle B; von Schweinitz D; Schneppenheim R; Leuschner I
    Genes Chromosomes Cancer; 2016 Dec; 55(12):925-931. PubMed ID: 27356182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic stratification for children with hepatoblastoma: the SIOPEL experience.
    Maibach R; Roebuck D; Brugieres L; Capra M; Brock P; Dall'Igna P; Otte JB; De Camargo B; Zsiros J; Zimmermann A; Aronson D; Childs M; Scopinaro M; Morland B; Plaschkes J; Czauderna P; Perilongo G
    Eur J Cancer; 2012 Jul; 48(10):1543-9. PubMed ID: 22244829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94.
    Fuchs J; Rydzynski J; Von Schweinitz D; Bode U; Hecker H; Weinel P; Bürger D; Harms D; Erttmann R; Oldhafer K; Mildenberger H;
    Cancer; 2002 Jul; 95(1):172-82. PubMed ID: 12115331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival after liver transplantation for hepatoblastoma: a 2-center experience.
    Browne M; Sher D; Grant D; Deluca E; Alonso E; Whitington PF; Superina RA
    J Pediatr Surg; 2008 Nov; 43(11):1973-81. PubMed ID: 18970927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatoblastoma.
    Sharma D; Subbarao G; Saxena R
    Semin Diagn Pathol; 2017 Mar; 34(2):192-200. PubMed ID: 28126357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children's Oncology Group.
    Meyers RL; Rowland JR; Krailo M; Chen Z; Katzenstein HM; Malogolowkin MH
    Pediatr Blood Cancer; 2009 Dec; 53(6):1016-22. PubMed ID: 19588519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of Patients Treated for Hepatoblastoma with Low Alpha-Fetoprotein and/or Small Cell Undifferentiated Histology: A Report from the Children's Hepatic Tumors International Collaboration (CHIC).
    Trobaugh-Lotrario AD; Maibach R; Aronson DC; Rangaswami A; Häberle B; O'Neill AF; Schmid I; Ansari M; Hishiki T; Ranganathan S; Alaggio R; de Krijger RR; Tanaka Y; Cho SJ; Vokuhl C; Maxwell R; Krailo M; Hiyama E; Czauderna P; Finegold M; Feusner JH; Malogolowkin MH; Meyers RL; Lopez-Terrada D
    Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of pulmonary metastases in hepatoblastoma--is the prognosis always poor?
    Wanaguru D; Shun A; Price N; Karpelowsky J
    J Pediatr Surg; 2013 Dec; 48(12):2474-8. PubMed ID: 24314189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing treatment and outcome of children with hepatoblastoma: analysis of a single center experience over the last 20 years.
    Ismail H; Broniszczak D; Kaliciński P; Dembowska-Bagińska B; Perek D; Teisseyre J; Kluge P; Kościesza A; Lembas A; Markiewicz M
    J Pediatr Surg; 2012 Jul; 47(7):1331-9. PubMed ID: 22813792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-enhanced CT features of hepatoblastoma: Can we predict histopathology?
    Baheti AD; Luana Stanescu A; Li N; Chapman T
    Clin Imaging; 2017; 44():33-37. PubMed ID: 28399447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis predicts survival following neo-adjuvant chemotherapy for hepatoblastoma.
    Venkatramani R; Wang L; Malvar J; Dias D; Sposto R; Malogolowkin MH; Mascarenhas L
    Pediatr Blood Cancer; 2012 Sep; 59(3):493-8. PubMed ID: 22190448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chromatin remodelling component SMARCB1/INI1 influences the metastatic behavior of colorectal cancer through a gene signature mapping to chromosome 22.
    Pancione M; Remo A; Zanella C; Sabatino L; Di Blasi A; Laudanna C; Astati L; Rocco M; Bifano D; Piacentini P; Pavan L; Purgato A; Greco F; Talamini A; Bonetti A; Ceccarelli M; Vendraminelli R; Manfrin E; Colantuoni V
    J Transl Med; 2013 Nov; 11():297. PubMed ID: 24286138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.